Strata Critical Medical (SRTA) Cash from Operations (2019 - 2026)

Strata Critical Medical has disclosed Cash from Operations across 8 years of filings, most recently posting 3885000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 1679.27% year-over-year to 3885000.0; the TTM figure through Mar 2026 stood at 44783000.0 (down 450.25% YoY), while the FY2025 annual figure was 48914000.0, down 1841.8% from the prior year.
• Cash from Operations improved to 3885000.0 in Q1 2026, from 8307000.0 in the prior quarter.
• Over the last five years, Cash from Operations for SRTA reached as high as 8429000.0 in Q2 2024 and fell as low as 37297000.0 in Q3 2025.
• The 5-year median for Cash from Operations is 8197000.0 (2023), against an average of 7442466.67.
• Annual changes were most pronounced in 2022 — Cash from Operations tumbled 1563.64% — and 2026, when it surged 1679.27%.
• A 5-year view of Cash from Operations shows it stood at 21675000.0 in 2022, then surged by 57.0% to 9320000.0 in 2023, then soared by 81.2% to 1752000.0 in 2024, then plunged by 374.14% to 8307000.0 in 2025, then soared by 146.77% to 3885000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 3885000.0, 8307000.0, and 37297000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.